RayzeBio Inc. Common Stoc...

NASDAQ: RYZB · Real-Time Price · USD
62.49
0.01 (0.02%)
At close: Feb 23, 2024, 10:00 PM

RayzeBio Common Stock Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2022 FY 2021
Period Ending Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
129.16M 50.57M
Short-Term Investments
167.09M 148.6M
Long-Term Investments
n/a n/a
Other Long-Term Assets
347K 385K
Receivables
n/a n/a
Inventory
n/a n/a
Other Current Assets
3.79M 3.26M
Total Current Assets
300.04M 202.43M
Property-Plant & Equipment
24.39M 13.57M
Goodwill & Intangibles
n/a n/a
Total Long-Term Assets
24.74M 13.96M
Total Assets
324.78M 216.38M
Account Payables
2.62M 1.13M
Deferred Revenue
n/a n/a
Short-Term Debt
1.14M 1.85M
Other Current Liabilities
6.69M 3.16M
Total Current Liabilities
10.46M 6.13M
Long-Term Debt
9.43M 7.21M
Other Long-Term Liabilities
416.19M 257.62M
Total Long-Term Liabilities
425.61M 264.82M
Total Liabilities
436.07M 270.96M
Total Debt
10.57M 9.06M
Common Stock
2K 2K
Retained Earnings
-130.12M -55.11M
Comprehensive Income
-553K -239K
Shareholders Equity
-111.29M -54.57M
Total Investments
167.09M 148.6M